Kezar Life Sciences, Inc.KZRNASDAQ
LOADING
|||
Net Income Growth Trend
Above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
18.08%
↑ 363% above average
Average (34q)
-6.88%
Historical baseline
Range
High:32.86%
Low:-115.09%
Volatility
-2150.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 18.08% |
| Q2 2025 | 17.23% |
| Q1 2025 | 18.11% |
| Q4 2024 | 0.47% |
| Q3 2024 | 5.73% |
| Q2 2024 | 0.51% |
| Q1 2024 | 32.86% |
| Q4 2023 | -39.64% |
| Q3 2023 | 4.96% |
| Q2 2023 | -9.50% |
| Q1 2023 | -22.10% |
| Q4 2022 | -1.87% |
| Q3 2022 | -10.26% |
| Q2 2022 | -1.02% |
| Q1 2022 | -12.75% |
| Q4 2021 | 1.73% |
| Q3 2021 | -11.57% |
| Q2 2021 | 0.25% |
| Q1 2021 | -18.76% |
| Q4 2020 | 3.08% |
| Q3 2020 | -18.83% |
| Q2 2020 | 5.11% |
| Q1 2020 | -4.52% |
| Q4 2019 | -4.71% |
| Q3 2019 | -4.93% |
| Q2 2019 | -14.08% |
| Q1 2019 | -32.17% |
| Q4 2018 | -2.10% |
| Q3 2018 | 16.41% |
| Q2 2018 | -36.95% |
| Q1 2018 | -115.09% |
| Q4 2017 | -10.58% |
| Q3 2017 | -10.64% |
| Q2 2017 | 16.70% |
| Q1 2017 | 0.00% |